Serum IgA antibodies to VCA and/or early antigens can be diagnostic for nasopharyngeal carcinoma; this is often interpreted as reflecting the mucosal origin of this EBV-associated tumour [5]. The gene discussed is CD79A; the disease is neoplasm.